JP Morgan Chase
IRWD icon

JP Morgan Chase’s Ironwood Pharmaceuticals IRWD Stock Holding History

JP Morgan Chase’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$382K Sell
118,191
-96,416
-45% -$395K ﹤0.01% 5174
2025
Q4 		$723K Buy
214,607
+102,450
+91% +$266K ﹤0.01% 4805
2025
Q3 		$147K Sell
112,157
-1,127
-1% -$1.17K ﹤0.01% 5691
2025
Q2 		$81.2K Sell
113,284
-1,589,349
-93% -$1.25M ﹤0.01% 5698
2025
Q1 		$2.5M Buy
1,702,633
+628,127
+58% +$1.5M ﹤0.01% 3704
2024
Q4 		$4.76M Buy
1,074,506
+767,641
+250% +$3.11M ﹤0.01% 3391
2024
Q3 		$1.26M Sell
306,865
-1,546,140
-83% -$8.31M ﹤0.01% 4323
2024
Q2 		$12.1M Buy
1,853,005
+667,780
+56% +$4.72M ﹤0.01% 2289
2024
Q1 		$10.3M Sell
1,185,225
-269,656
-19% -$3.27M ﹤0.01% 2454
2023
Q4 		$16.6M Buy
1,454,881
+973,576
+202% +$9.63M ﹤0.01% 1995
2023
Q3 		$4.63M Sell
481,305
-809,116
-63% -$7.93M ﹤0.01% 2898
2023
Q2 		$13.7M Buy
1,290,421
+655,313
+103% +$7.04M ﹤0.01% 2012
2023
Q1 		$6.68M Sell
635,108
-1,353,519
-68% -$15.2M ﹤0.01% 2600
2022
Q4 		$24.6M Buy
1,988,627
+1,407,459
+242% +$16M ﹤0.01% 1507
2022
Q3 		$6.02M Sell
581,168
-136,236
-19% -$1.54M ﹤0.01% 2583
2022
Q2 		$8.27M Sell
717,404
-75,396
-10% -$888K ﹤0.01% 2324
2022
Q1 		$9.97M Sell
792,800
-484,108
-38% -$5.55M ﹤0.01% 2375
2021
Q4 		$14.9M Sell
1,276,908
-489,386
-28% -$6M ﹤0.01% 2087
2021
Q3 		$23.1M Buy
1,766,294
+843,827
+91% +$10.9M ﹤0.01% 1652
2021
Q2 		$11.9M Sell
922,467
-237,308
-20% -$2.72M ﹤0.01% 2284
2021
Q1 		$13M Buy
1,159,775
+655,094
+130% +$6.92M ﹤0.01% 2122
2020
Q4 		$5.75M Buy
504,681
+422,052
+511% +$4.62M ﹤0.01% 2689
2020
Q3 		$778K Buy
82,629
+1,975
+2% +$19.6K ﹤0.01% 3775
2020
Q2 		$832K Sell
80,654
-36,746
-31% -$376K ﹤0.01% 3613
2020
Q1 		$1.19M Sell
117,400
-14,645
-11% -$172K ﹤0.01% 3298
2019
Q4 		$1.76M Sell
132,045
-41,529
-24% -$458K ﹤0.01% 3467
2019
Q3 		$1.49M Buy
173,574
+117,964
+212% +$1.15M ﹤0.01% 3592
2019
Q2 		$600K Sell
55,610
-439,319
-89% -$4.92M ﹤0.01% 4151
2019
Q1 		$5.61M Buy
494,929
+186,509
+60% +$2.08M ﹤0.01% 2498
2018
Q4 		$2.68M Buy
308,420
+177,755
+136% +$2.04M ﹤0.01% 3076
2018
Q3 		$2.02M Sell
130,665
-555,490
-81% -$8.78M ﹤0.01% 3458
2018
Q2 		$11M Buy
686,155
+569,153
+486% +$8.42M ﹤0.01% 2063
2018
Q1 		$1.51M Sell
117,002
-416,359
-78% -$5.19M ﹤0.01% 3441
2017
Q4 		$6.7M Buy
533,361
+509,947
+2,178% +$6.66M ﹤0.01% 2434
2017
Q3 		$311K Sell
23,414
-61,731
-73% -$849K ﹤0.01% 3972
2017
Q2 		$1.35M Sell
85,145
-254,392
-75% -$3.7M ﹤0.01% 3272
2017
Q1 		$4.85M Buy
339,537
+328,599
+3,004% +$4.49M ﹤0.01% 2450
2016
Q4 		$140K Buy
10,938
+8,945
+449% +$113K ﹤0.01% 4291
2016
Q3 		$27K Sell
1,993
-658,873
-100% -$7.7M ﹤0.01% 4140
2016
Q2 		$7.24M Sell
660,866
-252,103
-28% -$2.46M ﹤0.01% 2051
2016
Q1 		$8.37M Buy
912,969
+12,061
+1% +$99.5K ﹤0.01% 1878
2015
Q4 		$8.74M Buy
900,908
+29,996
+3% +$290K ﹤0.01% 1903
2015
Q3 		$7.6M Buy
870,912
+248,587
+40% +$2.32M ﹤0.01% 1958
2015
Q2 		$6.29M Sell
622,325
-800,879
-56% -$9.31M ﹤0.01% 2255
2015
Q1 		$19.1M Buy
1,423,204
+1,305,117
+1,105% +$17.1M ﹤0.01% 1462
2014
Q4 		$1.51M Buy
118,087
+75,372
+176% +$863K ﹤0.01% 3121
2014
Q3 		$463K Buy
+42,715
New +$489K ﹤0.01% 3706
2014
Q2 		– Sell
-317,175
Closed -$3.27M – 3567
2014
Q1 		$3.27M Buy
317,175
+161,862
+104% +$1.82M ﹤0.01% 2314
2013
Q4 		$1.51M Sell
155,313
-19,577
-11% -$176K ﹤0.01% 2932
2013
Q3 		$1.73M Buy
174,890
+59,622
+52% +$585K ﹤0.01% 2902
2013
Q2 		$958K Buy
+115,268
New +$1.4M ﹤0.01% 3286

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase's IRWD Position: Q1 2026 in Review

JP Morgan Chase reduced its Ironwood Pharmaceuticals (IRWD) stake by 45% in Q1 2026, selling an estimated $395K and leaving 118,191 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #5174.

JP Morgan Chase first reported a position in IRWD in Q2 2013 and has held it in 51 quarters since. The position peaked at $24.6M in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • JP Morgan Chase held 118,191 shares of Ironwood Pharmaceuticals worth $382K as of Q1 2026.
  • JP Morgan Chase sold 96,416 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $395K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5174 holding.
  • JP Morgan Chase first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • JP Morgan Chase's Ironwood Pharmaceuticals position peaked at $24.6M in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.